InsidersTradesSigma
Track the Bicara Therapeutics Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares are quoted on the US market, under the supervision of SEC (Form 4). Market capitalisation: €1.6bn. The latest transaction was filed on 12 August 2026 (Levée d'options). Among the most active insiders: Cohlhepp Ryan. The full history is accessible without an account.
82
Insider Decl.
n/a
Thresholds
€4m
1 ops.
Buy Volume
€4m
20 ops.
Sell Volume
47Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 August 2026
Declarations82 total
18,750 shares@ US$3.7898Common StockSEC:0001470831-26-000812:0
18,750 shares@ US$27.9751Common StockSEC:0001470831-26-000812:1
10,000 shares@ US$3.7898Common StockSEC:0001470831-26-000813:0
10,000 shares@ US$27.975Common StockSEC:0001470831-26-000813:1
10,000 shares@ US$27.830.015% mcap13.7% of flowCommonSEC144:0001969223-26-000869
18,750 shares@ US$27.830.028% mcap16.9% of flowCommonSEC144:0001969223-26-000872
10,000 shares@ US$3.78980.0020% mcap2.2% of flowCommon StockSEC:0001470831-26-000714:0
9,972 shares@ US$28.41630.015% mcap16.3% of flowCommon StockSEC:0001470831-26-000714:1
28 shares@ US$29.680.0000% mcap0.0% of flowCommon StockSEC:0001470831-26-000714:2
10,000 shares@ US$29.680.016% mcap21.0% of flowCommonSEC144:0001969223-26-000775
18,750 shares@ US$3.78980.0038% mcap2.8% of flowCommon StockSEC:0001470831-26-000701:0
22,833 shares@ US$28.75890.035% mcap26.0% of flowCommon StockSEC:0001470831-26-000701:1
4,306 shares@ US$29.79610.0068% mcap5.1% of flowCommon StockSEC:0001470831-26-000701:2
1,075 shares@ US$30.35490.0017% mcap1.3% of flowCommon StockSEC:0001470831-26-000701:3
536 shares@ US$29.000.0008% mcap0.6% of flowCommon StockSEC:0001470831-26-000701:4
50,000 shares@ US$28.56160.075% mcap100.0% of flowCommonSEC144:0001950047-26-006962
28,750 shares@ US$30.250.046% mcap73.7% of flowCommonSEC144:0001969223-26-000773
25 of 82 declarations
Acerca de Bicara Therapeutics Inc.
Bicara Therapeutics Inc. es una empresa biofarmacéutica centrada en el desarrollo de terapias innovadoras para el tratamiento del cáncer. Emplea enfoques basados en la inmunoterapia para atacar tumores.